A PHASE-I AND PHARMACOKINETIC STUDY WITH 21-DAY CONTINUOUS INFUSION OF EPIRUBICIN

被引：23

作者：

DEVRIES, EGE

GREIDANUS, J

MULDER, NH

NIEWEG, MB

POSTMUS, PE

SCHIPPER, DL

SLEIJFER, DT

UGES, DRA

WILLEMSE, PHB

机构：

[1] STATE UNIV GRONINGEN HOSP,DEPT MED ONCOL,9713 EZ GRONINGEN,NETHERLANDS

[2] STATE UNIV GRONINGEN HOSP,DEPT PULM DIS,9713 EZ GRONINGEN,NETHERLANDS

[3] STATE UNIV GRONINGEN HOSP,DEPT PHARM,9713 EZ GRONINGEN,NETHERLANDS

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 09期

关键词：

D O I：

10.1200/JCO.1987.5.9.1445

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1445 / 1451

页数：7

共 27 条

[1] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[2]

CAMAGGI CM, 1982, CANCER TREAT REP, V66, P1819

[3] EPIRUBICIN - A REVIEW OF THE PHARMACOLOGY, CLINICAL ACTIVITY, AND ADVERSE-EFFECTS OF AN ADRIAMYCIN ANALOG [J].

CERSOSIMO, RJ ;

HONG, WK .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :425-439

[4]

CREECH RH, 1980, CANCER, V46, P433, DOI 10.1002/1097-0142(19800801)46:3<433::AID-CNCR2820460302>3.0.CO

[5]

2-6

[6]

DEFLORA A, 1986, P NATL ACAD SCI USA, V83, P7029

[7]

DIEM K, 1968, WISSENSCHAFTLICHE TA, P610

[8] 4'-EPI-DOXORUBICIN, A NEW ANALOG OF DOXORUBICIN - A PRELIMINARY OVERVIEW OF PRE-CLINICAL AND CLINICAL-DATA [J].

GANZINA, F .

CANCER TREATMENT REVIEWS, 1983, 10 (01) :1-22

[9]

GARNICK MB, 1983, CANCER TREAT REP, V67, P133

[10]

JASPERS L, 1985, CANCER CHEMOTHER PHA, V14, pS135

← 1 2 3 →